Pranas Šerpytis


A retrospective analysis of last 300 inputs of IABP was done. The study included 99 women (33.0%) and 201 men (67.0%). Average age – 69.5±10.4 years, the survivors – 68.3 year, survivors are 4.2 years younger (p = 0.002). The average hospitalization stay was 17.3±14.9 days, while the average IABP insertion duration – 110.7 hours. Patients who survived, had IABP inserted for 9 hours longer (p = 0.001). It is statistically determined that no medical history of MI or CABG predicted worse outcome (p> 0.05). Cardiogenic shock was the most common indication for use of the IABP (n=124, 41.3%). This indication had the highest mortality (n = 63, 50.8%). Patients with acute MI had the highest survival rate (77.98.7%). The average BNP level of the survived patients was 2.5 times lower (p <0.001). The mean creatinine value was 30% higher (p <0.001) for dead patients. The analysis of vital indicators changes had shown, that after IABP insertion, heart rate, systolic and diastolic blood pressure remain unchanged, however left ventricular ejection fraction has increased up to 4.4% (12.5%, p <0.05). Intraaortic balloon pump therapy has a beneficial effect on hemodynamic parameters and the complication rate is low. IABP remains a clinically and cost effective preventive and treatment device. Also, the admission BNP and creatinine levels, can reliably predict a negative outcome.

Keyword(s): Intra-aortic counterpulsation balloon pump, IABP, Results, Cardiogenic shock
DOI: 10.5200/147
Full TextPDF